LEKOKLAR 250mg / 5ml oral suspension pellets medication leaflet

J01FA09 clarithromycin • Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins

Clarithromycin is an antibiotic used to treat a wide range of bacterial infections, including respiratory infections, skin infections, and ear infections. It belongs to the macrolide class and works by inhibiting bacterial protein synthesis, thereby stopping bacterial growth.

The medication is taken orally, usually in the form of tablets or suspension, and should be used as directed by your doctor. It is important to complete the full course of treatment, even if symptoms improve, to prevent the development of bacterial resistance.

Side effects may include nausea, diarrhea, abdominal pain, or changes in taste. In rare cases, severe allergic reactions, liver damage, or other complications may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver diseases or cardiac arrhythmias, as these may affect the safety of clarithromycin use.

General data about LEKOKLAR 250mg / 5ml

Substance: clarithromycin

Date of last drug list: 01-07-2020

Commercial code: W58393002

Concentration: 250mg / 5ml

Pharmaceutical form: oral suspension pellets

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: SALUTAS PHARMA GMBH - GERMANIA

Holder: SANDOZ S.R.L. - ROMANIA

Number: 10951/2018/02

Shelf life: 3 years-after packing for marketing; after reconstitution-14 days

Concentrations available for clarithromycin

125mg/5ml, 250mg, 250mg/5ml, 250mg/ml, 500mg